mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0007 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0007 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.16 |
0.0007 |
mRNA |
EKB-569 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0008 |
mRNA |
OSI-027 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0008 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
mRNA |
Midostaurin |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
GSK2126458 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |